Pesticides/Agrochemicals Stocks in India
Pesticides/Agrochemicals: UPL Ltd owns the largest revenue base; Titan Biotech Ltd has the fastest current growth.
Nifty Pesticides/Agrochemicals Index — Constituents & Performance
The Pesticides/Agrochemicals companies below are the listed Indian Pesticides/Agrochemicals universe this page tracks — the same constituent set people search for as the Nifty Pesticides/Agrochemicals index. Every figure is equal-weighted across those companies, so one large constituent cannot set the reading. Each number carries its own as-of date.
How has Pesticides/Agrochemicals moved against NIFTY 500?
The line below covers up to 5.2 years and opens on the 5Y view; the buttons cut it shorter. Over the most recent two of them this sector is 3% ahead of NIFTY 500. Earnings across its companies grew 6% on average over the last four reported quarters — close to flat.
RS — · 9/23 >200d (+2) · 5/23 lead (−6) · EPS 13/22↑
Both lines start at 200 in the same week, so the distance between them is the whole story: the sector line is an equal-weighted index of its 23 companies. The bars underneath are trailing 12-month earnings per share, one bar per reported quarter, each member rebased to 100 at the start and the sector taking the median — so a price line pulling away from flat bars is a re-rating, not earnings. A bar turns red when that figure is lower than the quarter before. Rules are fixed and applied identically everywhere on this site: ahead by 5% or more over three months, or behind by 20% or more over a year while earnings grew 20% or more. Hover any point to read both values and the gap. This is a description of what the numbers did, not advice.
Is Pesticides/Agrochemicals outperforming NIFTY 500?
Pesticides/Agrochemicals has underperformed NIFTY 500 by 22.2% over the last 52 weeks. Over 13 weeks the gap is a shortfall of 1.6%. 5 of 22 covered companies currently beat NIFTY on Mansfield relative strength, so leadership inside the sector is selective. Titan Biotech Ltd is the strongest against the sector itself at +41.7%. Readings are as of 2026-07-19.
Sector metric: 15.9 as of 2026-07-19 · BROADENING · falling.
The central tension: the companies with the most scale are not necessarily the companies creating the most change.
Start with scale. Then earnings trajectory. Then business quality. Only after those three agree should price leadership carry much weight.
Bottom line
Pesticides/Agrochemicals has underperformed NIFTY 500 by 22.2% over 52 weeks and 1.6% over 13 weeks. 5 of 22 covered companies beat NIFTY on Mansfield relative strength, while 6 of 22 beat the sector itself. UPL Ltd leads with revenue of ₹51,839 crore, based on 24 of 24 comparable companies through Mar 2026.
4-Factor Sector Score
An additive sector-relative research score. The four displayed point contributions always equal the total: Growth & earnings (35), Capital efficiency (25), Valuation (20), and Relative strength (20). Missing or stale evidence is absorbed inside the affected factor, never applied as a hidden adjustment.
How this score is built, and what the marks mean
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Titan Biotech Ltd524717 | 69.3/100Favorable setup78% evidence | ASLEEP | 29.1/35 Revenue 31.8% · PAT 38.7% · OPM change 6.9 pp 83% evidence | 20.2/25 ROCE 22.8% · OPM 19.9% 76% evidence | 6.0/20 P/E 57.8× · PEG — 50% evidence | 14.0/20 RS sector 41.7% · RS bench 39.3% · 1Y 371.1%5 of 12 weeks ahead 100% evidence |
| Exact sum: 29.1 + 20.2 + 6 + 14 = 69.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Sharda Cropchem LtdSHARDACROP | 65.3/100Favorable setup97% evidence | ASLEEP | 23.7/35 Revenue 18.5% · PAT 49% · OPM change -5 pp 95% evidence | 18.5/25 ROCE 30.2% · OPM 17% 95% evidence | 19.2/20 P/E 11.8× · PEG 0.26 100% evidence | 3.9/20 RS sector -10.9% · RS bench -13.7% · 1Y -24.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 23.7 + 18.5 + 19.2 + 3.9 = 65.3 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -10.9% and the one-year return is -24.6%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 3Punjab Chemicals & Crop Protection LtdPUNJABCHEM | 61.8/100Mixed-positive evidence81% evidence | ASLEEP | 22.7/35 Revenue 8.2% · PAT 43.5% · OPM change 1 pp 95% evidence | 18.3/25 ROCE 18.6% · OPM 12% 95% evidence | 12.1/20 P/E 21× · PEG — 50% evidence | 8.7/20 RS sector -6.2% · RS bench -2.6% · 1Y -13.2%1 of 10 weeks ahead 70% evidence |
| Exact sum: 22.7 + 18.3 + 12.1 + 8.7 = 61.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Bayer CropScience LtdBAYERCROP | 61.7/100Mixed-positive evidence70% evidence | ASLEEP | 21.4/35 Revenue 3.7% · PAT 21.7% · OPM change 2.1 pp 83% evidence | 19.1/25 ROCE 20.1% · OPM 18.4% 95% evidence | 8.5/20 P/E 387× · PEG — 15% evidence | 12.7/20 RS sector 9.4% · RS bench -10.7% · 1Y -33.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 21.4 + 19.1 + 8.5 + 12.7 = 61.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Dharmaj Crop Guard LtdDHARMAJ | 61.1/100Mixed-positive evidence62% evidence | TURNING | 23.8/35 Revenue 19.6% · PAT 56.9% · OPM change 2.7 pp 62% evidence | 12.9/25 ROCE 16.4% · OPM 4.5% 95% evidence | 10.6/20 P/E 16.6× · PEG — 15% evidence | 13.8/20 RS sector 5% · RS bench -2.5% · 1Y -13.2%4 of 10 weeks ahead 70% evidence |
| Exact sum: 23.8 + 12.9 + 10.6 + 13.8 = 61.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Advance Agrolife LtdADVANCE | 56.3/100Thin evidence · provisional56% evidence | TURNING | 21.4/35 Revenue 27% · PAT 37.6% · OPM change 4.3 pp 83% evidence | 14.8/25 ROCE 19.3% · OPM 10.8% 95% evidence | 10.1/20 P/E 22.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 10 weeks ahead 0% evidence |
| Exact sum: 21.4 + 14.8 + 10.1 + 10 = 56.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7UPL LtdUPL | 54.2/100Mixed-positive evidence90% evidence | ASLEEP | 20.6/35 Revenue 11.2% · PAT 100% · OPM change -1 pp 88% evidence | 9.3/25 ROCE 10.1% · OPM 19% 100% evidence | 12.5/20 P/E 28.3× · PEG 0.5 100% evidence | 11.8/20 RS sector 4.9% · RS bench -12.2% · 1Y -16.3%0 of 10 weeks ahead 70% evidence |
| Exact sum: 20.6 + 9.3 + 12.5 + 11.8 = 54.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8India Pesticides LtdIPL | 54.0/100Mixed-positive evidence81% evidence | TURNING | 20.0/35 Revenue 17% · PAT 10.1% · OPM change -2 pp 95% evidence | 13.6/25 ROCE 16.7% · OPM 14% 95% evidence | 14.1/20 P/E 16.5× · PEG — 50% evidence | 6.3/20 RS sector -11.9% · RS bench -12.1% · 1Y -27.3%4 of 11 weeks ahead 70% evidence |
| Exact sum: 20 + 13.6 + 14.1 + 6.3 = 54 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Jubilant Ingrevia LtdJUBLINGREA | 52.7/100Mixed-positive evidence93% evidence | FADING | 18.2/35 Revenue 11% · PAT 11.2% · OPM change 1 pp 100% evidence | 10.2/25 ROCE 11.4% · OPM 15% 100% evidence | 6.4/20 P/E 36.8× · PEG 2.37 65% evidence | 17.9/20 RS sector 11.8% · RS bench 7.8% · 1Y -5.6%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.2 + 10.2 + 6.4 + 17.9 = 52.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Bharat Rasayan LtdBHARATRAS | 51.6/100Mixed-positive evidence77% evidence | ASLEEP | 17.1/35 Revenue 5.8% · PAT 3.5% · OPM change 4 pp 83% evidence | 16.5/25 ROCE 17.4% · OPM 16% 95% evidence | 14.7/20 P/E 13.3× · PEG — 50% evidence | 3.3/20 RS sector -33.2% · RS bench -34.6% · 1Y -51.5%0 of 11 weeks ahead 70% evidence |
| Exact sum: 17.1 + 16.5 + 14.7 + 3.3 = 51.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Bhagiradha Chemicals & Industries LtdBHAGCHEM | 51.0/100Mixed-positive evidence88% evidence | TURNING | 23.6/35 Revenue 21.7% · PAT 31.1% · OPM change 7.3 pp 65% evidence | 5.8/25 ROCE 4.5% · OPM 12.3% 100% evidence | 2.0/20 P/E 207× · PEG 3.04 100% evidence | 19.6/20 RS sector 22.5% · RS bench 17.9% · 1Y -0.7%11 of 12 weeks ahead 100% evidence |
| Exact sum: 23.6 + 5.8 + 2 + 19.6 = 51 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12GSP Crop Science LtdGSPCROP | 50.4/100Thin evidence · provisional59% evidence | TURNING | 16.5/35 Revenue 21.2% · PAT 37.8% · OPM change -4 pp 88% evidence | 14.3/25 ROCE 19% · OPM 9% 100% evidence | 9.6/20 P/E 26.8× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —3 of 3 weeks ahead 0% evidence |
| Exact sum: 16.5 + 14.3 + 9.6 + 10 = 50.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Dhanuka Agritech LtdDHANUKA | 46.6/100Mixed-negative evidence96% evidence | ASLEEP | 8.3/35 Revenue 0.9% · PAT -5.3% · OPM change -2.5 pp 88% evidence | 19.1/25 ROCE 28.3% · OPM 22.5% 100% evidence | 13.0/20 P/E 15.6× · PEG 1.72 100% evidence | 6.2/20 RS sector -12.4% · RS bench -16.2% · 1Y -40.9%4 of 12 weeks ahead 100% evidence |
| Exact sum: 8.3 + 19.1 + 13 + 6.2 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Sumitomo Chemical India LtdSUMICHEM | 45.4/100Mixed-negative evidence94% evidence | TURNING | 12.1/35 Revenue -3.6% · PAT 3.9% · OPM change 1 pp 100% evidence | 19.0/25 ROCE 22.1% · OPM 22% 100% evidence | 4.0/20 P/E 44.6× · PEG 4 100% evidence | 10.3/20 RS sector -8.2% · RS bench 6% · 1Y -12.8%9 of 10 weeks ahead 70% evidence |
| Exact sum: 12.1 + 19 + 4 + 10.3 = 45.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 15Rallis India LtdRALLIS | 45.3/100Mixed-negative evidence91% evidence | ASLEEP | 16.1/35 Revenue 7.3% · PAT -28.4% · OPM change 2.6 pp 95% evidence | 9.3/25 ROCE 12.8% · OPM 15.2% 95% evidence | 11.4/20 P/E 26.7× · PEG 0.89 100% evidence | 8.5/20 RS sector -1.8% · RS bench -20.7% · 1Y -39.2%0 of 10 weeks ahead 70% evidence |
| Exact sum: 16.1 + 9.3 + 11.4 + 8.5 = 45.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16NACL Industries LtdNACLIND | 44.9/100Mixed-negative evidence94% evidence | TURNING | 28.1/35 Revenue 11.9% · PAT 100% · OPM change 3 pp 100% evidence | 4.4/25 ROCE 8.1% · OPM 11% 100% evidence | 3.8/20 P/E 171× · PEG 2.02 100% evidence | 8.6/20 RS sector -12.5% · RS bench 3.8% · 1Y -26.9%10 of 10 weeks ahead 70% evidence |
| Exact sum: 28.1 + 4.4 + 3.8 + 8.6 = 44.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Astec Lifesciences LtdASTEC | 44.9/100Mixed-negative evidence63% evidence | ASLEEP | 23.3/35 Revenue 9.4% · PAT 47.7% · OPM change 11.2 pp 71% evidence | 2.6/25 ROCE -5.4% · OPM -0.8% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.0/20 RS sector -3.5% · RS bench -9.3% · 1Y -27.2%7 of 10 weeks ahead 70% evidence |
| Exact sum: 23.3 + 2.6 + 10 + 9 = 44.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Meghmani Organics LtdMOL | 44.3/100Mixed-negative evidence74% evidence | TURNING | 20.6/35 Revenue -7.8% · PAT 100% · OPM change 7 pp 95% evidence | 9.4/25 ROCE 6.7% · OPM 18% 95% evidence | 10.2/20 P/E 21.3× · PEG — 15% evidence | 4.1/20 RS sector -33.7% · RS bench -13.6% · 1Y -42.8%3 of 10 weeks ahead 70% evidence |
| Exact sum: 20.6 + 9.4 + 10.2 + 4.1 = 44.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Insecticides India LtdINSECTICID | 43.8/100Mixed-negative evidence77% evidence | ASLEEP | 11.9/35 Revenue 7% · PAT -1.4% · OPM change -2 pp 83% evidence | 13.0/25 ROCE 15.8% · OPM 6% 95% evidence | 11.7/20 P/E 13.5× · PEG — 50% evidence | 7.2/20 RS sector -8.5% · RS bench -9.5% · 1Y -38.7%7 of 10 weeks ahead 70% evidence |
| Exact sum: 11.9 + 13 + 11.7 + 7.2 = 43.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 20Excel Industries LtdEXCELINDUS | 43.1/100Mixed-negative evidence70% evidence | TURNING | 14.4/35 Revenue 12% · PAT -11.8% · OPM change 0 pp 83% evidence | 8.6/25 ROCE 6.1% · OPM 8% 95% evidence | 10.9/20 P/E 16.4× · PEG — 15% evidence | 9.2/20 RS sector -4.6% · RS bench -2.6% · 1Y -27.3%2 of 10 weeks ahead 70% evidence |
| Exact sum: 14.4 + 8.6 + 10.9 + 9.2 = 43.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21Epigral LtdEPIGRAL | 41.3/100Mixed-negative evidence94% evidence | ASLEEP | 6.5/35 Revenue 4.8% · PAT -37.4% · OPM change -2 pp 100% evidence | 14.3/25 ROCE 15.5% · OPM 25% 100% evidence | 16.5/20 P/E 17.3× · PEG 0.43 100% evidence | 4.0/20 RS sector -32.9% · RS bench -17.5% · 1Y -40.9%7 of 10 weeks ahead 70% evidence |
| Exact sum: 6.5 + 14.3 + 16.5 + 4 = 41.3 · Decision use: Cheap but unconfirmed: require improving earnings before treating the valuation as an opportunity. | ||||||
| 22P I Industries LtdPIIND | 40.9/100Mixed-negative evidence90% evidence | ASLEEP | 6.6/35 Revenue -15.9% · PAT -20.5% · OPM change -3 pp 88% evidence | 15.5/25 ROCE 15% · OPM 22% 100% evidence | 10.6/20 P/E 34.7× · PEG 1.71 100% evidence | 8.2/20 RS sector -3.4% · RS bench -15.3% · 1Y -32.8%0 of 10 weeks ahead 70% evidence |
| Exact sum: 6.6 + 15.5 + 10.6 + 8.2 = 40.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Best Agrolife LtdBESTAGRO | 29.7/100Adverse evidence81% evidence | TURNING | 7.9/35 Revenue -24.1% · PAT -56.5% · OPM change 8 pp 95% evidence | 9.0/25 ROCE 5.2% · OPM 20% 95% evidence | 7.0/20 P/E 22.9× · PEG — 50% evidence | 5.8/20 RS sector -30.7% · RS bench -8.5% · 1Y -36.9%1 of 11 weeks ahead 70% evidence |
| Exact sum: 7.9 + 9 + 7 + 5.8 = 29.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Heranba Industries LtdHERANBA | 25.7/100Adverse evidence65% evidence | ASLEEP | 11.7/35 Revenue 13.1% · PAT -80% · OPM change -2.7 pp 62% evidence | 1.2/25 ROCE -1.6% · OPM -7% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 2.8/20 RS sector -22% · RS bench -25.7% · 1Y -51.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 11.7 + 1.2 + 10 + 2.8 = 25.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Market action
Titan Biotech Ltd has the strongest one-year price move in Pesticides/Agrochemicals at +371.1%. It also leads on Mansfield relative strength against NIFTY at +39.3%. 5 of 22 covered companies are above zero on that measure. Every line covers 313 weekly closes through 2026-07-31.
Every company, the sector's own index and NIFTY 500 all start level on the left edge of the window, so only the distance between the lines counts — the highest line has risen the most since then, and the chart at the top of this page is drawn the same way. It opens on one year; the buttons beside it stretch that to three or five.
How far ahead of or behind NIFTY 500 each company has been running, measured against its own recent average of that comparison, so the flat line at zero IS NIFTY 500: above it the company is beating the market, below it the market is beating the company. It opens on one year.
The same measure taken against Pesticides/Agrochemicals itself instead of the whole market, so the flat line at zero is the sector: above it the company is beating its own peers, which is the sharper test of the two. It opens on one year.
Revenue Scale & Growth Durability
UPL Ltd has the highest Revenue among the 24 Pesticides/Agrochemicals companies compared here, at ₹51,839 crore. P I Industries Ltd is next at ₹6,713 crore. Titan Biotech Ltd has the highest Revenue growth at 31.8%, so level and change sit with different companies. 24 of 24 companies report a comparable reading, the latest through Mar 2026.
What the numbers say: UPL Ltd is the scale leader at ₹51,839 crore, 672.2% ahead of P I Industries Ltd. Titan Biotech Ltd's growth is 31.8% from a ₹206 crore base, with 14 reported observations in the 20-quarter window. Treat the growth leader as an acceleration candidate, not as equally proven scale.
Investor read: UPL Ltd is the scale benchmark; Titan Biotech Ltd is the acceleration watch. Promote the challenger only if growth persists and converts into margin and returns.
This conclusion weakens if: UPL Ltd's growth falls below Titan Biotech Ltd's for two consecutive comparable reports while operating margin also compresses.
On every company-comparison chart on this page: solid lines show level, dotted lines show change when “Both” is selected, and a missing report breaks the line rather than being invented.
All-company data · latest reported quarter
In every all-company table on this page, each figure is the company’s latest single reported quarter. The rankings above them use trailing-twelve-month or current-market values, so a company can legitimately show a different number in each.
| Company | Revenue | Revenue growth | Reported |
|---|---|---|---|
| UPL Ltd UPL | ₹18.3K Cr | 18% | Mar 2026 |
| P I Industries Ltd PIIND | ₹1.6K Cr | -12% | Mar 2026 |
| Jubilant Ingrevia Ltd JUBLINGREA | ₹1.3K Cr | 25% | Jun 2026 |
| Bayer CropScience Ltd BAYERCROP⚠ unverified | ₹1.1K Cr | 5.1% | Mar 2026 |
| Sharda Cropchem Ltd SHARDACROP | ₹1.1K Cr | 9.0% | Jun 2026 |
| Sumitomo Chemical India Ltd SUMICHEM | ₹1.1K Cr | 0.6% | Jun 2026 |
| Rallis India Ltd RALLIS | ₹1.0K Cr | 6.8% | Jun 2026 |
| Epigral Ltd EPIGRAL | ₹705 Cr | 16% | Jun 2026 |
| Meghmani Organics Ltd MOL⚠ unverified | ₹543 Cr | -12% | Jun 2026 |
| Dhanuka Agritech Ltd DHANUKA | ₹483 Cr | 9.3% | Mar 2026 |
| Insecticides India Ltd INSECTICID⚠ unverified | ₹426 Cr | 19% | Mar 2026 |
| GSP Crop Science Ltd GSPCROP | ₹402 Cr | 31% | Mar 2026 |
| Best Agrolife Ltd BESTAGRO | ₹396 Cr | 3.9% | Jun 2026 |
| NACL Industries Ltd NACLIND | ₹383 Cr | -15% | Jun 2026 |
| Punjab Chemicals & Crop Protection Ltd PUNJABCHEM⚠ unverified | ₹347 Cr | 8.4% | Jun 2026 |
| Heranba Industries Ltd HERANBA⚠ unverified | ₹319 Cr | -4.8% | Mar 2026 |
| Bharat Rasayan Ltd BHARATRAS⚠ unverified | ₹308 Cr | 0.3% | Mar 2026 |
| Excel Industries Ltd EXCELINDUS⚠ unverified | ₹281 Cr | 13% | Mar 2026 |
| India Pesticides Ltd IPL⚠ unverified | ₹252 Cr | -8.4% | Jun 2026 |
| Dharmaj Crop Guard Ltd DHARMAJ⚠ unverified | ₹234 Cr | 11% | Mar 2026 |
| Bhagiradha Chemicals & Industries Ltd BHAGCHEM | ₹158 Cr | 29% | Mar 2026 |
| Advance Agrolife Ltd ADVANCE⚠ unverified | ₹124 Cr | 38% | Mar 2026 |
| Astec Lifesciences Ltd ASTEC⚠ unverified | ₹84 Cr | -7.7% | Jun 2026 |
| Titan Biotech Ltd 524717 | ₹49 Cr | 39% | Mar 2026 |
Full 20-quarter history · every available company
Revenue · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Revenue growth · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Operating Economics & Margin Trend
Epigral Ltd has the highest OPM among the 24 Pesticides/Agrochemicals companies compared here, at 25%. Dhanuka Agritech Ltd is next at 22.5%. Astec Lifesciences Ltd has the highest Margin change at +11.2 percentage points, so level and change sit with different companies. 24 of 24 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Epigral Ltd leads opm at 25%; Astec Lifesciences Ltd leads margin change at +11.2 percentage points.
Investor read: Epigral Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current margin change signal.
All-company data · latest reported quarter
| Company | OPM | Margin change | Reported |
|---|---|---|---|
| Epigral Ltd EPIGRAL | 25% | −2.0 pp | Jun 2026 |
| Dhanuka Agritech Ltd DHANUKA | 23% | −2.5 pp | Mar 2026 |
| P I Industries Ltd PIIND | 22% | −3.0 pp | Mar 2026 |
| Sumitomo Chemical India Ltd SUMICHEM | 22% | +1.0 pp | Jun 2026 |
| Best Agrolife Ltd BESTAGRO | 20% | +8.0 pp | Jun 2026 |
| Titan Biotech Ltd 524717 | 20% | +6.9 pp | Mar 2026 |
| UPL Ltd UPL | 19% | −1.0 pp | Mar 2026 |
| Bayer CropScience Ltd BAYERCROP⚠ unverified | 18% | +2.1 pp | Mar 2026 |
| Meghmani Organics Ltd MOL⚠ unverified | 18% | +7.0 pp | Jun 2026 |
| Sharda Cropchem Ltd SHARDACROP | 17% | −5.0 pp | Jun 2026 |
| Bharat Rasayan Ltd BHARATRAS⚠ unverified | 16% | +4.0 pp | Mar 2026 |
| Rallis India Ltd RALLIS | 15% | +2.6 pp | Jun 2026 |
| Jubilant Ingrevia Ltd JUBLINGREA | 15% | +1.0 pp | Jun 2026 |
| India Pesticides Ltd IPL⚠ unverified | 14% | −2.0 pp | Jun 2026 |
| Bhagiradha Chemicals & Industries Ltd BHAGCHEM | 12% | +7.3 pp | Mar 2026 |
| Punjab Chemicals & Crop Protection Ltd PUNJABCHEM⚠ unverified | 12% | +1.0 pp | Jun 2026 |
| NACL Industries Ltd NACLIND | 11% | +3.0 pp | Jun 2026 |
| Advance Agrolife Ltd ADVANCE⚠ unverified | 11% | +4.3 pp | Mar 2026 |
| GSP Crop Science Ltd GSPCROP | 9.0% | −4.0 pp | Mar 2026 |
| Excel Industries Ltd EXCELINDUS⚠ unverified | 8.0% | 0.0 pp | Mar 2026 |
| Insecticides India Ltd INSECTICID⚠ unverified | 6.0% | −2.0 pp | Mar 2026 |
| Dharmaj Crop Guard Ltd DHARMAJ⚠ unverified | 4.5% | +2.7 pp | Mar 2026 |
| Astec Lifesciences Ltd ASTEC⚠ unverified | -0.8% | +11.2 pp | Jun 2026 |
| Heranba Industries Ltd HERANBA⚠ unverified | -7.0% | −2.7 pp | Mar 2026 |
Full 20-quarter history · every available company
OPM · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Margin change · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Profit Scale & Acceleration
UPL Ltd has the highest Net profit among the 24 Pesticides/Agrochemicals companies compared here, at ₹2,220 crore. P I Industries Ltd is next at ₹1,320 crore. Meghmani Organics Ltd has the highest Profit growth at the 100% top of the scoring scale, so level and change sit with different companies.
What the numbers say: UPL Ltd leads with ₹2,220 crore of TTM profit, 68.2% above P I Industries Ltd. Meghmani Organics Ltd shows ≥100% on the scoring scale (220% uncapped) growth from a ₹64 crore profit base. Compare the size of the base and persistence before ranking acceleration above profit scale.
Investor read: UPL Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current profit growth signal.
All-company data · latest reported quarter
| Company | Net profit | Profit growth | Reported |
|---|---|---|---|
| UPL Ltd UPL | ₹1.3K Cr | 20% | Mar 2026 |
| Sumitomo Chemical India Ltd SUMICHEM | ₹215 Cr | 21% | Jun 2026 |
| P I Industries Ltd PIIND | ₹200 Cr | -39% | Mar 2026 |
| Bayer CropScience Ltd BAYERCROP⚠ unverified | ₹162 Cr | 13% | Mar 2026 |
| Rallis India Ltd RALLIS | ₹125 Cr | 32% | Jun 2026 |
| Jubilant Ingrevia Ltd JUBLINGREA | ₹106 Cr | 41% | Jun 2026 |
| Epigral Ltd EPIGRAL | ₹100 Cr | -38% | Jun 2026 |
| Dhanuka Agritech Ltd DHANUKA | ₹98 Cr | 29% | Mar 2026 |
| Sharda Cropchem Ltd SHARDACROP | ₹88 Cr | -38% | Jun 2026 |
| Meghmani Organics Ltd MOL⚠ unverified | ₹48 Cr | 269% | Jun 2026 |
| Best Agrolife Ltd BESTAGRO | ₹41 Cr | 105% | Jun 2026 |
| Bharat Rasayan Ltd BHARATRAS⚠ unverified | ₹38 Cr | 52% | Mar 2026 |
| India Pesticides Ltd IPL⚠ unverified | ₹23 Cr | -34% | Jun 2026 |
| Punjab Chemicals & Crop Protection Ltd PUNJABCHEM⚠ unverified | ₹22 Cr | 4.8% | Jun 2026 |
| NACL Industries Ltd NACLIND | ₹21 Cr | 62% | Jun 2026 |
| GSP Crop Science Ltd GSPCROP | ₹20 Cr | -9.1% | Mar 2026 |
| Insecticides India Ltd INSECTICID⚠ unverified | ₹12 Cr | -14% | Mar 2026 |
| Excel Industries Ltd EXCELINDUS⚠ unverified | ₹12 Cr | 0.0% | Mar 2026 |
| Advance Agrolife Ltd ADVANCE⚠ unverified | ₹7 Cr | 422% | Mar 2026 |
| Titan Biotech Ltd 524717 | ₹7 Cr | 66% | Mar 2026 |
| Bhagiradha Chemicals & Industries Ltd BHAGCHEM | ₹4 Cr | 29% | Mar 2026 |
| Dharmaj Crop Guard Ltd DHARMAJ⚠ unverified | ₹4 Cr | -36% | Mar 2026 |
| Astec Lifesciences Ltd ASTEC⚠ unverified | ₹-19 Cr | -2,500% | Jun 2026 |
| Heranba Industries Ltd HERANBA⚠ unverified | ₹-58 Cr | -105% | Mar 2026 |
Full 20-quarter history · every available company
Net profit · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Profit growth · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Return On Capital Employed
Sharda Cropchem Ltd has the highest ROCE among the 24 Pesticides/Agrochemicals companies compared here, at 30.2%. Dhanuka Agritech Ltd is next at 28.3%. NACL Industries Ltd has the highest ROCE change at +26.4 percentage points, so level and change sit with different companies. 24 of 24 companies report a comparable reading, the latest through Jun 2026.
What the numbers say: Sharda Cropchem Ltd leads ROCE at 30.2%, 1.9 percentage points above Dhanuka Agritech Ltd. NACL Industries Ltd has the strongest latest improvement at +26.4 percentage points. Read the leader beside the density of its reported history: a sparse high return is a candidate; a repeated high return is evidence of durability.
Investor read: Sharda Cropchem Ltd sets the level benchmark; use the change leader as an inflection watch only after another comparable report confirms it.
This conclusion weakens if: The next two comparable reports reverse the current roce change signal.
All-company data · latest reported quarter
| Company | ROCE | ROCE change | Reported |
|---|---|---|---|
| Bayer CropScience Ltd BAYERCROP⚠ unverified | 25% | +4.8 pp | Mar 2026 |
| Sharda Cropchem Ltd SHARDACROP | 22% | +7.2 pp | Jun 2026 |
| Dhanuka Agritech Ltd DHANUKA | 20% | −5.3 pp | Mar 2026 |
| GSP Crop Science Ltd GSPCROP | 19% | −4.7 pp | Mar 2026 |
| Punjab Chemicals & Crop Protection Ltd PUNJABCHEM⚠ unverified | 18% | +2.0 pp | Jun 2026 |
| Sumitomo Chemical India Ltd SUMICHEM | 17% | −1.6 pp | Jun 2026 |
| Advance Agrolife Ltd ADVANCE⚠ unverified | 17% | −17.8 pp | Mar 2026 |
| Insecticides India Ltd INSECTICID⚠ unverified | 17% | −0.3 pp | Mar 2026 |
| Dharmaj Crop Guard Ltd DHARMAJ⚠ unverified | 16% | +3.8 pp | Mar 2026 |
| Epigral Ltd EPIGRAL | 14% | −7.5 pp | Jun 2026 |
| India Pesticides Ltd IPL⚠ unverified | 14% | +3.3 pp | Jun 2026 |
| Bharat Rasayan Ltd BHARATRAS⚠ unverified | 13% | +0.1 pp | Mar 2026 |
| Jubilant Ingrevia Ltd JUBLINGREA | 12% | +0.1 pp | Jun 2026 |
| Rallis India Ltd RALLIS | 12% | +2.8 pp | Jun 2026 |
| P I Industries Ltd PIIND | 11% | −6.2 pp | Mar 2026 |
| UPL Ltd UPL | 11% | +1.4 pp | Mar 2026 |
| NACL Industries Ltd NACLIND | 9.9% | +26.4 pp | Jun 2026 |
| Bhagiradha Chemicals & Industries Ltd BHAGCHEM | 4.1% | +1.0 pp | Mar 2026 |
| Excel Industries Ltd EXCELINDUS⚠ unverified | 3.9% | −1.2 pp | Mar 2026 |
| Meghmani Organics Ltd MOL⚠ unverified | 3.2% | +1.3 pp | Jun 2026 |
| Heranba Industries Ltd HERANBA⚠ unverified | -3.3% | −7.7 pp | Mar 2026 |
| Astec Lifesciences Ltd ASTEC⚠ unverified | -11% | +10.1 pp | Jun 2026 |
Full 20-quarter history · every available company
ROCE · reported quarter history
Showing the 12 largest of 22 companies with a series here. The remaining 10 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
ROCE change · reported quarter history
Showing the 12 largest of 22 companies with a series here. The remaining 10 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
Valuation Against Growth & Quality
Sharda Cropchem Ltd has the lowest PEG among the 24 Pesticides/Agrochemicals companies compared here, at 0.26×. Epigral Ltd is next at 0.43×. The same company also holds the lowest P/E, at 11.8×. 10 of 24 companies report a comparable reading, the latest through Jun 2026. Its PEG series carries 7 reported observations across the 20-quarter window.
What the numbers say: Sharda Cropchem Ltd has the lowest comparable PEG at 0.26×, 39.5% below Epigral Ltd. Only 10 of 24 companies have earnings and growth steady enough for the ratio to mean anything, so no broad “cheapest stock” conclusion is defensible unless the current multiple, own-history position and growth durability agree.
Investor read: Treat valuation as permission to investigate, never as a standalone reason to buy.
This conclusion weakens if: The next two comparable reports reverse the current p/e signal.
All-company data · latest reported quarter
| Company | PEG | P/E | Reported |
|---|---|---|---|
| Sumitomo Chemical India Ltd SUMICHEM | 4.0 | 39.1 | Jun 2026 |
| Bhagiradha Chemicals & Industries Ltd BHAGCHEM | 3.0 | 185.3 | Mar 2026 |
| Jubilant Ingrevia Ltd JUBLINGREA | 2.4 | 34.4 | Jun 2026 |
| NACL Industries Ltd NACLIND | 2.0 | -56.6 | Jun 2026 |
| Dhanuka Agritech Ltd DHANUKA | 1.7 | 14.5 | Mar 2026 |
| P I Industries Ltd PIIND | 1.7 | 31.2 | Mar 2026 |
| Rallis India Ltd RALLIS | 0.9 | 28.0 | Jun 2026 |
| UPL Ltd UPL | 0.5 | 26.5 | Mar 2026 |
| Epigral Ltd EPIGRAL | 0.4 | 14.5 | Jun 2026 |
| Sharda Cropchem Ltd SHARDACROP | 0.3 | 11.6 | Jun 2026 |
| Titan Biotech Ltd 524717 | — | 66.2 | Mar 2026 |
| Bayer CropScience Ltd BAYERCROP⚠ unverified | — | 30.3 | Mar 2026 |
| GSP Crop Science Ltd GSPCROP | — | 16.2 | Mar 2026 |
| Bharat Rasayan Ltd BHARATRAS⚠ unverified | — | 14.7 | Mar 2026 |
| Insecticides India Ltd INSECTICID⚠ unverified | — | 11.4 | Mar 2026 |
| India Pesticides Ltd IPL⚠ unverified | — | 15.7 | Jun 2026 |
| Astec Lifesciences Ltd ASTEC⚠ unverified | — | 110.6 | Jun 2026 |
| Punjab Chemicals & Crop Protection Ltd PUNJABCHEM⚠ unverified | — | 19.3 | Jun 2026 |
| Meghmani Organics Ltd MOL⚠ unverified | — | 43.7 | Jun 2026 |
| Excel Industries Ltd EXCELINDUS⚠ unverified | — | 14.0 | Mar 2026 |
| Dharmaj Crop Guard Ltd DHARMAJ⚠ unverified | — | 16.1 | Mar 2026 |
| Advance Agrolife Ltd ADVANCE⚠ unverified | — | 13.5 | Mar 2026 |
| Heranba Industries Ltd HERANBA⚠ unverified | — | 24.3 | Mar 2026 |
| Best Agrolife Ltd BESTAGRO | — | 62.6 | Jun 2026 |
Full 20-quarter history · every available company
PEG · reported quarter history
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
P/E · reported quarter history
Showing the 12 largest of 24 companies with a series here. The remaining 12 are complete in the plain-text rendition and the trace payload — nothing is dropped from the data, only from this grid.
Bayer CropScience Ltd · BAYERCROP⚠ unverified
Bhagiradha Chemicals & Industries Ltd · BHAGCHEM
Dhanuka Agritech Ltd · DHANUKA
Epigral Ltd · EPIGRAL
GSP Crop Science Ltd · GSPCROP
Jubilant Ingrevia Ltd · JUBLINGREA
NACL Industries Ltd · NACLIND
P I Industries Ltd · PIIND
Rallis India Ltd · RALLIS
Sharda Cropchem Ltd · SHARDACROP
Sumitomo Chemical India Ltd · SUMICHEM
UPL Ltd · UPL
What can make this comparison misleading?
This Pesticides/Agrochemicals comparison names 5 specific ways its own evidence can mislead, all listed below. All 24 companies here report on comparable dates, so no rank carries a stale marker. 11 draw at least one figure from a second feed with too little overlap to cross-check. A high growth rate can still be a low-base artefact.
Keep these limits visible
- A high growth rate can be a low-base artefact. The page keeps level and change separate for that reason.
- A high ROCE can be temporary or flattered by a small capital base. Read it beside margin, cash conversion and reinvestment.
- The 4-Factor Sector Score ranks research priority, not portfolio action. Management quality, catalysts and risks need equally fresh evidence before capital is deployed.
- An “all companies” line chart preserves completeness, but rank changes should be checked against reporting dates before drawing a conclusion.
- 11 companies draw at least one figure from a second data feed with too little overlapping history to cross-check against the primary source; they are marked unverified wherever those figures appear.
How was this comparison built?
This comparison is built from the reported filings of 24 Pesticides/Agrochemicals companies, normalized to a common ₹ scale and a shared quarter axis of up to 20 quarters each. Fundamentals run through Jun 2026 and market data through 2026-07-31. A second data feed fills gaps only after identity and scale reconciliation, and missing observations are never interpolated.
How a second data feed is admitted, and what happens when it disagrees
A second feed is read only after its reported income is matched against the primary source on at least three overlapping periods. Where the two agree the figures fill silently. Where there is too little shared history to compare, the figures are still drawn — they are the only evidence there is — and marked ⚠ unverified everywhere they appear. Where the two are known to disagree, nothing from the second feed is drawn and the affected company is named under the chart it is missing from.
Pesticides/Agrochemicals company comparison FAQs
These 24 answers restate the Pesticides/Agrochemicals comparison above in question form. Every one is computed from the same 24 companies and the same reported filings as the rankings and charts, current through Jun 2026. Price and relative-strength answers run through 2026-07-31. Nothing here is estimated, and none of it is a recommendation.
Is the Pesticides/Agrochemicals sector outperforming NIFTY 500?
Pesticides/Agrochemicals has underperformed NIFTY 500 by 22.2% over 52 weeks and 1.6% over 13 weeks. 5 of 22 covered companies beat NIFTY on Mansfield relative strength, while 6 of 22 beat the sector itself.
Which Pesticides/Agrochemicals company is largest by revenue?
UPL Ltd leads with revenue of ₹51,839 crore, based on 24 of 24 comparable companies through Mar 2026.
Which Pesticides/Agrochemicals company is growing fastest?
Titan Biotech Ltd has the fastest current revenue growth at 31.8%, across 24 of 24 comparable companies.
Which Pesticides/Agrochemicals company has the strongest 4-Factor Sector Score?
Titan Biotech Ltd ranks first at 69.3/100 with 78.1% evidence confidence. The score prioritizes research; it is not a buy recommendation.
Which Pesticides/Agrochemicals company has the lowest comparable PEG?
Sharda Cropchem Ltd has the lowest comparable PEG at 0.26, among 10 of 24 companies whose earnings and growth are steady enough for the ratio to mean anything.
How much history does this Pesticides/Agrochemicals comparison include?
The page compares up to 20 reported quarters per company for fundamentals, returns and valuation, ending Jun 2026. Missing observations remain blank rather than being estimated.
How is the 4-Factor Sector Score calculated?
The four visible contributions add directly: growth and earnings up to 35 points, capital efficiency up to 25, valuation up to 20, and relative strength up to 20. Missing or stale evidence moves only the affected contribution toward neutral.
What is the Nifty Pesticides/Agrochemicals index?
The Nifty Pesticides/Agrochemicals index tracks India's listed Pesticides/Agrochemicals companies as a single basket. This page follows the same 24 companies and equal-weights them, so every company's weekly return counts once whatever it is worth, and the reading belongs to the Pesticides/Agrochemicals sector rather than to its largest constituent. Figures are as of Jun 2026.
Which are the best Pesticides/Agrochemicals stocks in India?
Ranked by this page's four-factor score, Titan Biotech Ltd places first among 24 listed Pesticides/Agrochemicals companies, followed by Sharda Cropchem Ltd. That is a ranking of published data — earnings, quality, valuation and market behaviour as of Jun 2026 — and not a recommendation; Sector Alpha is not registered with SEBI as an investment adviser.
How many Pesticides/Agrochemicals stocks are listed in India?
This comparison covers 24 listed Pesticides/Agrochemicals companies in India, each above the size floor the site applies, with 20 quarters of reported figures per company where the filings exist. The full ranked list is on this page, as of Jun 2026.
Which Pesticides/Agrochemicals company is the biggest?
UPL Ltd is the largest, with trailing-twelve-month revenue of ₹51,839 crore, ahead of P I Industries Ltd at ₹6,713 crore. That covers 24 of 24 companies with comparable reporting through Mar 2026.
Which Pesticides/Agrochemicals company has the best profit margins?
Epigral Ltd has the highest operating margin at 25%, from 24 of 24 comparable companies. Astec Lifesciences Ltd shows the biggest recent improvement, at +11.2 percentage points. A high margin matters most when it is holding or rising, not when it is peaking.
Which Pesticides/Agrochemicals company makes the most profit?
UPL Ltd earns the most, at ₹2,220 crore of trailing-twelve-month net profit, from 24 of 24 comparable companies. Meghmani Organics Ltd has the fastest profit growth at 100%, though growth off a small or recovering profit base overstates how much has actually changed.
Which Pesticides/Agrochemicals company earns the highest return on capital?
Sharda Cropchem Ltd leads on return on capital employed at 30.2%, across 24 of 24 companies. Read it beside the length of its reported history: a high return that repeats for years is evidence of a durable business, while a single high reading can be a small capital base or one good year.
Which Pesticides/Agrochemicals stock is the cheapest?
On PEG — where a LOWER number is cheaper — Sharda Cropchem Ltd screens cheapest at 0.26×. Only 10 of 24 companies have earnings and growth steady enough for the ratio to mean anything, so this is not a sector-wide "cheapest stock" verdict. Cheap on a multiple is a reason to investigate, never a reason to buy on its own.
Is the Pesticides/Agrochemicals sector beating the market?
Pesticides/Agrochemicals has underperformed NIFTY 500 by 22.2% over the last 52 weeks and 1.6% over 13 weeks, measured on an equal-weight index of its current members. Inside the sector, 5 of 22 covered companies are beating the market on their own. Sector strength does not transfer evenly to every stock in it.
Which Pesticides/Agrochemicals stock has the strongest price momentum?
Titan Biotech Ltd has the strongest relative strength against NIFTY 500. Relative strength answers last, after growth, quality and valuation: price can move well before the fundamentals confirm it, and sometimes without them confirming at all.
Which Pesticides/Agrochemicals company scores highest for research priority?
Titan Biotech Ltd scores 69.3 out of 100 with 78.1% evidence confidence, from 29.1 points on growth and earnings, 20.2 on capital efficiency, 6 on valuation and 14 on relative strength. This ranks what deserves work next. It is not a buy recommendation, and management quality, catalysts and risk still need separate research.
How many Pesticides/Agrochemicals companies does this comparison cover, and over what period?
It compares 24 listed companies over up to 20 reported quarters of fundamentals, ending Jun 2026, plus weekly price and relative-strength history. Membership is the full sector list — nothing is dropped for having thin data.
What is the total market cap of the Pesticides/Agrochemicals sector?
The 24 Pesticides/Agrochemicals companies on this page carry ₹1,96,811 crore of combined market value. UPL Ltd is the largest at ₹50,997 crore, about 26% of the sector's total on its own. Market value moves with price, so this reading is dated 2026-08-05.
What is the Pesticides/Agrochemicals sector's P/E ratio?
The median price-to-earnings ratio across the 24 Pesticides/Agrochemicals companies on this page is 22.9×, measured on the 22 that report a comparable figure. A sector-level history for this multiple is not held here, so this is a cross-section of today, not a comparison with the sector’s own past. Figures are as of 2026-08-05.
How is the Pesticides/Agrochemicals sector performing?
5 of the 22 covered Pesticides/Agrochemicals companies are beating NIFTY 500 on Mansfield relative strength. The sector itself is 22.2% behind NIFTY 500 over 52 weeks on an equal-weight index of its current members. Readings are as of 2026-08-05.
Why are some values on this page blank?
A blank means that company did not report a comparable figure for that period, so nothing is shown. Missing observations are never interpolated, carried forward, or replaced with a similar-looking accounting line, and a company with missing evidence has its research score pulled toward neutral rather than being scored as bad.
Is this investment advice?
No. Every figure here is a deterministic calculation from reported company filings and market data, published for research. It contains no recommendation to buy or sell any security, does not account for your circumstances, and is not a substitute for advice from a licensed adviser.